Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Optic Neuritis and Multiple Sclerosis

Remyelination Strategies for Multiple Sclerosis

Multiple Sclerosis Epidemiology

Early Signs of Multiple Sclerosis

Multiple sclerosis and smoking

Secondary Progressive Multiple Sclerosis (SPMS)

Benign Multiple Sclerosis (MS)

Heat Intolerance in Multiple Sclerosis

At-Home Physiotherapy Exercises for Multiple Sclerosis

Epigenetics for Multiple Sclerosis

See more featured articles »

How is RRMS Different from PPMS and SPMS?

Cognitive Impairment and Multiple Sclerosis

Primary Progressive Multiple Sclerosis (PPMS)

Types of Multiple Sclerosis (MS)

What Causes Multiple Sclerosis?

Multiple Sclerosis and Women’s Health

Multiple Sclerosis in Children

Multiple sclerosis and beta interferon

Relapsing-Remitting Multiple Sclerosis (RRMS)

Working Towards Earlier Diagnosis of Multiple Sclerosis

Anti-Myelin Antibodies in Multiple Sclerosis

Multiple Sclerosis and Pregnancy

Latest Multiple Sclerosis News and Research

Study reveals key role of Egr-1 in controlling autoimmune diseases

Autoimmune diseases, like multiple sclerosis result when the body's immune system starts to attack its own cells. Regulatory T cells, a subtype of T cells play a critical role in suppressing these attacks.

14 Jul 2025

New blood test predicts multiple sclerosis years before symptoms

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the onset of symptoms.

14 Jul 2025

Egr-1 gene identified as crucial regulator of regulatory T cells in multiple sclerosis

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect millions of people worldwide.

11 Jul 2025

Researchers create over 400 types of nerve cells from stem cells

Nerve cells are not just nerve cells. Depending on how finely we distinguish, there are several hundred to several thousand different types of nerve cell in the human brain according to the latest calculations.

11 Jul 2025

Physical fitness associated with better cognition in people with relapsing-remitting MS

Good physical performance is associated with better cognition in people with relapsing-remitting MS, according to a recent study by the University of Eastern Finland. Good functional capacity was also clearly related to cognition and physical performance.

8 Jul 2025

Neural stem cell grafts show promise for myelin repair in multiple sclerosis

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system.

7 Jul 2025

Illness expectations play a crucial role in asthma progression and patient-reported outcomes

Individual expectations about one's health can influence him/her future condition and the speed of the progression of a disease: in fact, a research conducted by researchers of psychology at the Università Cattolica del Sacro Cuore, Milan campus, shows that, after a diagnosis of asthma, people who are optimistic about their health will have a slower progression of the disease.

3 Jul 2025

New MRI technology reveals brain metabolism in unprecedented detail

A new technology that uses clinical MRI machines to image metabolic activity in the brain could give researchers and clinicians unique insight into brain function and disease, researchers at the University of Illinois Urbana-Champaign report.

2 Jul 2025

Engineered protein silences harmful T cells in autoimmune disease

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, multiple sclerosis, shows a new study in mice.

1 Jul 2025

Living in disadvantaged neighborhoods linked to Alzheimer’s biomarkers

People living in more disadvantaged neighborhoods may be more likely to have biomarkers for inflammation and Alzheimer's disease, according to a study published June 25, 2025, in Neurology, the medical journal of the American Academy of Neurology.

26 Jun 2025

Study finds nearly double risk of depression and anxiety in autoimmune patients

Living with an autoimmune disease is linked to a near doubling in the risk of persistent mental health issues, such as depression, generalised anxiety, and bipolar disorder, with these risks higher in women than in men, finds a large population-based UK study, published in the open access journal BMJ Mental Health.

25 Jun 2025

New PET radiotracer offers clearer view of brain inflammation

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2025 Annual Meeting.

24 Jun 2025

Endometriosis linked to higher odds of autoimmune conditions

New research links endometriosis to autoimmune diseases, revealing shared mechanisms that may lead to earlier diagnosis and targeted treatments for patients.

23 Jun 2025

Brain age gap may influence the relationship between cognitive impairment risk factors

The difference between the brain's predicted age and actual chronological age, called a brain age gap, may influence the relationship between cognitive impairment risk factors, like high blood pressure and diabetes, and a person's cognitive performance, also known as thinking and memory skills, according to a study published June 18, 2025, in Neurology, the medical journal of the American Academy of Neurology.

19 Jun 2025

Food insecurity, neighborhood disadvantage, and lack of social support affect stroke outcomes

Having poor access to food, living in a disadvantaged neighborhood and not having strong friend and family support may lead to worse outcomes after stroke, according to a study published June 18, 2025, in Neurology® Clinical Practice, an official journal of the American Academy of Neurology.

19 Jun 2025

Mitochondrial dysfunction drives cerebellar damage in multiple sclerosis

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have inflammation in the cerebellum, the part of the brain that helps control movement and balance, potentially leading to tremors, poor coordination, and trouble with motor control.

16 Jun 2025

Healthy lifestyle habits may shield aging cells from brain disorders

Stroke and dementia as well as late-life depression are more common in people who have a biomarker of aging called short leukocyte telomere length, according to a study published on June 11, 2025, online in Neurology, the medical journal of the American Academy of Neurology.

11 Jun 2025

Accelerated biological aging found in children with multiple sclerosis

Researchers from University of California San Diego School of Medicine have discovered that children living with multiple sclerosis (MS) show signs of accelerated biological aging, even in their teenage years.

9 Jun 2025

Scientists identify genetic clues linking air pollution to neurodegeneration

This review highlights how air pollution and occupational inhalation exposures may contribute to neurodegenerative disorders by triggering epigenetic changes. The authors stress the urgent need for advanced research to identify early biomarkers and guide protective health strategies for high-risk populations.

6 Jun 2025

Personalized exercise and coaching could improve health of people with neuromuscular diseases

While many people with neuromuscular diseases currently face a future without a cure, a new study finds that a personalized exercise and coaching program could improve their fitness and overall health.

4 Jun 2025